18th Orphan Drugs & Rare Diseases 2022 Americas
Sponsors & Exhibitors
Early Access Care LLC
Early Access Care helps international clients with effective integrated solutions customized to their early access needs. Early Access Care specializes in pre-approval early access, managing the end-to-end (request intake to delivery at physician) process. Our goal is to Make Access More Accessible™.
We offer comprehensive high-touch services to manage requests globally.
Tanner Pharma Group is a specialist pharmaceutical services provider headquartered in Charlotte, NC USA with offices in the United Kingdom, Switzerland, Ireland and Brazil. With a focus on improving patient lives by increasing access to medicines around the world, the company has developed a portfolio of service offerings that provide international commercialization and patient access through licensing, managed access programs, global access programs and clinical trial services, as well as donation programs through biopharmaceutical and non-profit partnerships. By partnering with Tanner Pharma Group, companies are able to focus on their primary markets while ensuring that patients and clinicians receive the products they need through compliant and controlled channels. For more information, visit www.tannerpharma.com.
Founded in 2007, InformedDNA is the country’s largest applied genomics solutions company, helping more people harness the full power of the genomics revolution. With the largest, lab-independent staff of board-certified genetics specialists in the U.S., InformedDNA helps to ensure that pharmaceutical and biotech companies, health plans, clinicians, and patients all have access to the highest quality genetic services.
Key offerings for pharmaceutical and biotech companies include design support for genetics-based clinical trials and studies, patient engagement and recruitment, physician education and engagement, clinical genetic counseling, and test ordering and interpretation services.
For more information, visit https://informeddna.com/lifesciences/
Smartway designs, implements and manages global programs that empower access to innovative therapies.
We partner with pharma and biotech organizations to deliver customized programs that transform lives. These partnerships have made us a leader in the provision of Expanded Access, Early Access, Compassionate Use and Named Patient Programs across 98 countries. Over the last 20 years, we’ve gained the experience it takes to strategically advice, design, initiate and manage global or regional programs with you.
We provide end-to-end solutions to manage complex EAPs. Whatever your size and scale, we’re dedicated to empowering patient access to the right therapy